about
AcromegalyClinical effectiveness and cost-effectiveness of pegvisomant for the treatment of acromegaly: a systematic review and economic evaluationSomatostatin analogues, dopamine agonists or growth hormone antagonists for pituitary adenoma-induced acromegalySomatostatin analogues, dopamine agonists or growth hormone antagonists for pituitary adenoma-induced acromegalyPituitary somatostatin receptor signalingGovernor Pio Pico, the monster of California...no more: lessons in neuroendocrinology.Acromegaly pathogenesis and treatmentAdvancing Treatment of Pituitary Adenomas through Targeted Molecular Therapies: The Acromegaly and Cushing Disease ParadigmsAcromegaly Presenting as Erectile Dysfunction: Case Reports and Review of the LiteraturePasireotide: a novel treatment for patients with acromegalyCombined treatment of somatostatin analogues with pegvisomant in acromegalyThe effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegalyCurious cases: Acromegaly and schizophrenia: an incidental association?Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumorsThe risks of overlooking the diagnosis of secreting pituitary adenomasGrowth hormone and reproduction: a review of endocrine and autocrine/paracrine interactionsNeurocognitive function in acromegaly after surgical resection of GH-secreting adenoma versus naïve acromegalyMeta-analysis on the effects of octreotide on tumor mass in acromegalyImplementing a screening program for acromegaly in Latin America: necessity versus feasibilityAcromegaly and McCune-Albright syndrome.Factors associated with biochemical remission after microscopic transsphenoidal surgery for acromegaly.Acromegaly without imaging evidence of pituitary adenoma.Lanreotide extended-release aqueous-gel formulation, injected by patient, partner or healthcare provider in patients with acromegaly in the United States: 1-year data from the SODA registry.Metabolic glucose status and pituitary pathology portend therapeutic outcomes in acromegaly.Reduced basal ATP synthetic flux of skeletal muscle in patients with previous acromegalyAcromegaly clinical trial methodology impact on reported biochemical efficacy rates of somatostatin receptor ligand treatments: a meta-analysis.Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas.Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extensionGH-secreting pituitary macroadenoma (acromegaly) associated with progressive dental malocclusion and refractory CPAP treatment.Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review.Management of acromegaly in Latin America: expert panel recommendationsEffectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-naïve patients with acromegaly.Isolated familial somatotropinoma: 11q13-loh and gene/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesisFeatures at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosedPolycythemia as rare secondary direct manifestation of acromegaly: management and single-centre epidemiological data.AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up.Metformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells.Gigantism caused by growth hormone secreting pituitary adenomaBenign and malignant nodular thyroid disease in acromegaly. Is a routine thyroid ultrasound evaluation advisable?Expert consensus document: A consensus on the medical treatment of acromegaly.
P2860
Q21202912-537D7161-A30D-45E0-A112-504FE1C02148Q21254711-40F2393E-3B46-4A9C-A81E-A8650EE9E55DQ24188346-91388BCA-40F4-4F0B-A796-AF90FC6504B1Q24239834-A999E749-32C8-4E78-8ECE-586E33E6AD51Q24631604-C8E8E801-0116-4BD5-8AA6-66CAEE91A979Q24645696-C7C5DBA0-BC43-46EE-AEC0-8B79E1CA12B0Q24647360-B39C7825-E312-429E-ADC2-B0DA9D875C8BQ26741707-3A44E500-2DB2-4D8E-A99B-9A0DBDD964B1Q26770145-C5E501DF-84EA-4DB4-9D99-C40B14E1E263Q26774437-9E6DFC6E-0B20-427F-9425-45EC7A64E99EQ26776366-3672A789-2534-413D-A789-E8D6D8603C76Q26796357-B09E48DE-CE4C-4F3D-A363-63EFFC3F4E6CQ27025160-8213F85A-4BD1-4886-AE16-D33476367792Q28069632-628FDE55-18C2-42F7-9062-E58978D6233BQ28076665-FAE3184B-10FD-4ECD-B1BD-1E939A2DE090Q28082801-B4238729-4E5C-45D0-B96C-A55DF79F5CAAQ28486006-30737850-4FC3-4BD0-A48E-D47FF459B44CQ28730120-EF7A10A3-FCE2-4014-9F6E-EF1B2969E155Q30251471-8152C6A0-2650-45FA-9039-F8CF4AACC51DQ30393779-CC3EAC15-FFFE-4A08-B34A-E07DE5F7CE6AQ30408371-D0FD5142-0D4C-47D4-BB13-8B648E786487Q30430884-CDA1A0E4-9155-4E9D-88F6-5E1853BC3F09Q30585813-7DF5F83A-7135-4D9E-8F24-C679AC12D245Q31139308-D9282978-5016-48CA-A7C1-1205839C4981Q33394238-BCD00800-068F-4898-ADDA-F6C94F98001CQ33569037-3B009065-CC05-4769-B21C-4287D1A19067Q33579615-3159F730-BE92-4AED-B53D-0896C28284D5Q33595081-5302FAC5-CE26-4700-85A8-29C97F3176D7Q33654893-C189BCA4-E05F-4901-8E6B-0DAFCC27247CQ33772673-F197516A-D8C5-4623-9CD4-31400E2F3578Q33794388-FF4D6C8F-3108-4DE0-A719-35F6834C411DQ33794409-A0EB1C1D-4BE6-4814-B2A6-C474F5F7F602Q33822855-F636C1C9-AD58-4079-885E-1FE123D63297Q33835825-03FB55B4-344A-415F-85AF-C7054AC1CEE8Q33876612-91985645-04C1-4920-B1C1-71577E149157Q33895577-65AE9491-DFAD-4F45-94D5-43688370DF9DQ33914014-C5955D49-1D75-429A-B07D-881C9E6D159CQ33964739-CF2E24F6-9F9D-4C7D-B557-C6738EB8E2D2Q34050636-ED65BDBC-B491-4564-85A0-72E778F8F005Q34406566-13CE7D8C-AA99-4B4D-999F-239D2FEA86A0
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Medical progress: Acromegaly.
@ast
Medical progress: Acromegaly.
@en
type
label
Medical progress: Acromegaly.
@ast
Medical progress: Acromegaly.
@en
prefLabel
Medical progress: Acromegaly.
@ast
Medical progress: Acromegaly.
@en
P356
P1476
Medical progress: Acromegaly.
@en
P2093
Shlomo Melmed
P304
P356
10.1056/NEJMRA062453
P407
P577
2006-12-01T00:00:00Z